What's Happening?
Zoetis Inc., a leading animal health company, has received marketing authorization from the European Commission for its Poulvac Procerta HVT-ND vaccine. This recombinant vector vaccine is designed to protect chickens against Newcastle disease and Marek's
disease with a single dose. The vaccine can be administered either in ovo or by subcutaneous injection at hatch. Newcastle disease is a significant concern in the poultry industry, causing mortality and production losses, as evidenced by recent outbreaks in Germany, Spain, and Poland. The vaccine uses the herpesvirus of turkey (HVT) as a vector, which has been a reliable method in poultry vaccination for two decades. The approval not only provides European poultry producers with a new tool to combat these diseases but also opens export opportunities to Southeast Asian markets where the vaccine is already approved.
Why It's Important?
The authorization of Poulvac Procerta HVT-ND is a critical development for the poultry industry, particularly in Europe, where Newcastle disease poses a significant threat. By offering a single-dose solution, Zoetis enhances the efficiency of disease management in poultry flocks, potentially reducing mortality rates and economic losses. The vaccine's approval also strengthens Zoetis's market position in Europe and Southeast Asia, supporting its strategy to expand its global footprint in animal health. This development underscores the importance of innovation in veterinary medicine and its role in safeguarding food security and animal welfare.
What's Next?
With the European Commission's approval, Zoetis plans to collaborate with veterinarians and poultry producers to integrate the vaccine into existing flock health programs. The company will likely focus on expanding its market reach in Europe and Southeast Asia, leveraging the vaccine's dual protection capability. Additionally, Zoetis may continue to develop and seek approval for other vaccines in the Poulvac Procerta range to address various poultry diseases, further solidifying its leadership in the animal health sector.
